Journal of Hematology - Supplements - Haematologica
Journal of Hematology - Supplements - Haematologica
Journal of Hematology - Supplements - Haematologica
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
31<br />
reported on the initial experience concerning<br />
633 searches activated for Italian patients and<br />
75 BMTs from UDs performed in GITMO institutions.<br />
5 In this report, we present the results <strong>of</strong><br />
the initial 696 UD BMTs performed in Italy<br />
between September 1989 and December 1999.<br />
Design and Methods<br />
IBMDR<br />
The IBMDR was established as a collaborative<br />
effort among the Regional Tissue Typing<br />
Laboratories. Its principles and policies are similar<br />
to those <strong>of</strong> other international Registries. 7-11<br />
IBMDR includes 17 local Registries and 100<br />
donor centres for the HLA class I and II serological<br />
typing <strong>of</strong> volunteer donors.<br />
Donor recruitment<br />
In December 1992 the number <strong>of</strong> donors was<br />
25,000. Over the following years more than<br />
20,000 new donors per year have been added to<br />
the registry. Currently, the IBMDR file contains<br />
data concerning approximately 260,000 volunteers.<br />
All <strong>of</strong> them are HLA-A,B serologically<br />
typed, while HLA-DR serological typing has also<br />
been performed on 86,000 (33%) <strong>of</strong> these registered<br />
donors. The DRB1 typing by PCR technique<br />
<strong>of</strong> 11,000 donors is also available. Once<br />
a month the IBMDR electronically sends its<br />
donor HLA phenotype file to the Bone Marrow<br />
Donors World Wide (BMDWW) directory, which<br />
includes more than 6,000,000 donors in its May<br />
2000 edition. 12<br />
All the Italian transplant centers (TC) involved<br />
in this programme are accredited through the<br />
GITMO to the IBMDR, to European Registries<br />
and to the National Marrow Program <strong>of</strong> the United<br />
States <strong>of</strong> America (NMDP), according to the World<br />
Marrow Donors Association standards.<br />
Matching criteria<br />
Before December 1991 most TC based their<br />
matching criteria on HLA-A,B,DR identity using<br />
serologic testing. After January 1992 class II antigens<br />
matching was confirmed by DNA techniques<br />
as previously described. 5<br />
Engraftment<br />
Neutrophil engraftment was defined as the<br />
first <strong>of</strong> 3 consecutive days with an absolute neutrophil<br />
count (ANC) >0.5×10 9 /L, whereas<br />
platelet engraftment was defined as the first <strong>of</strong><br />
3 consecutive days with an untransfused platelet<br />
count >50×10 9 /L.<br />
Data collection and statistical analysis<br />
Essential data regarding all donor-recipient<br />
pairs, and information concerning the harvesting<br />
procedure were obtained by the IBMDR data<br />
centre. Information on the BMT procedure and<br />
on the recipients follow-up were collected every<br />
year by the GITMO Registry. Univariate analysis<br />
was performed for relapse, for disease-free survival<br />
(DFS), and for transplant-related mortality<br />
(TRM). TRM was defined as mortality due to<br />
any cause other than disease progression in<br />
patients with haematological malignancies. Life<br />
tables (Kaplan-Meier estimates) were calculated<br />
at 3 years to measure the proportion <strong>of</strong> patients<br />
alive or, for malignancies, alive and disease-free.<br />
Data were updated as <strong>of</strong> December 31 st , 1999.<br />
Results<br />
The search<br />
Between September 1 st 1988 and December<br />
31 st 1999 the search for an UD was started for<br />
2,620 patients. Half <strong>of</strong> them were activated during<br />
the last three years. During the last 12<br />
months, a formal search was started each month<br />
for approximately 40 new Italian patients.<br />
Probability <strong>of</strong> finding a matched donor<br />
At least one HLA-A,B,DRB1 matched donor<br />
was found for 54% <strong>of</strong> the patients. At least one<br />
1 antigen mismatched donor was found for 66%<br />
<strong>of</strong> the patients. At least one HLA-A, B, CW,<br />
DRB, DQA, DQB matched donor was found for<br />
28% <strong>of</strong> the patients.<br />
As <strong>of</strong> December 1999, 696 Italian patients<br />
had undergone UD BMT in one <strong>of</strong> the 31 TC<br />
participating in this program. Three hundred sixty-seven<br />
<strong>of</strong> them were over 18 years <strong>of</strong> age, while,<br />
329 were 18 years old or less. Half <strong>of</strong> them were<br />
transplanted during the last 25 months. In 1999<br />
each month approximately 15 new Italian<br />
patients underwent UD BMT. Details on the<br />
activity <strong>of</strong> the 31 TC are reported in the Appendix.<br />
The characteristics <strong>of</strong> donors and recipients<br />
listed according to the type <strong>of</strong> disease that led to<br />
transplant are reported in Table 1.<br />
Donor Registries<br />
The first UD BMT performed in Italy was made<br />
possible in March 1989 by a donor listed with<br />
the Anthony Nolan Research Foundation. The<br />
first UD marrow provided by the IBMDR was<br />
grafted in March 1991. By December 1999, 347<br />
donors had been provided by the IBMDR and<br />
349 by other Registries, as shown in Table 2. As<br />
<strong>of</strong> 1997 the IBMDR has become the main<br />
source <strong>of</strong> donors for Italian patients.<br />
Donor Recipient matching<br />
Six hundred out <strong>of</strong> 696 pairs were HLA-<br />
A,B,DRB1 matched, while 80 pairs were mismatched<br />
for at least one antigen. Data concerning<br />
the remaining 16 pairs are missing.<br />
Details on matching by recipient age are reported<br />
in Table 3.<br />
haematologica vol. 85(supplement to n. 11):November 2000